# Endocannabinoid System Research: Cannabis PTSD Meta-Analysis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-ptsd-meta-analysis-trauma-focused-treatment/ > **Published:** 2026-03-08T12:47:48-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:10:22-04:00 > **Clinical Summary:** Explore the cannabis PTSD meta-analysis revealing trauma-focused treatment efficacy for patients with co-occurring substance use disorders. --- #### Clinical Takeaway Trauma-focused treatments remain effective for PTSD even when patients are actively using cannabis, including those with co-occurring [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/). Clinicians should not withhold or delay evidence-based PTSD care based on a patient’s [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) status. ### #5 Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data. **Citation:** Hill Melanie L et al. *[Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and trauma-focused treatment for co-occurring posttraumatic stress disorder and [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) disorders: A meta-analysis of individual patient data.* Journal of [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/). 2024. PMID: 38266511. **Study type:** Meta-Analysis, Journal Article, Research Support, N.I.H., Extramural  |  **Topic area:** Anxiety & PTSD  |  **CED Score:** 12 Design: 6 Journal: 0 N: 4 Recency: 1 Pop: 2 Human: 1 Risk: -2 Why This Matters This meta-analysis clarifies whether cannabis use compromises treatment response to evidence-based trauma-focused therapies in patients with comorbid PTSD and [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/), addressing a critical clinical gap since many practitioners remain uncertain about treating these patients effectively. The findings establish whether trauma-focused interventions maintain efficacy across cannabis use status, which directly informs treatment planning and patient selection for this high-risk population. Understanding differential treatment outcomes by cannabis use status enables clinicians to set appropriate expectations and optimize therapeutic approaches for individuals with these highly prevalent co-occurring conditions. **Quality Gate Alerts:** - Preclinical only **Abstract:** High rates of cannabis use among people with posttraumatic stress disorder (PTSD) have raised questions about the efficacy of evidence-based PTSD treatments for individuals reporting cannabis use, particularly those with co-occurring alcohol or other [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) disorders (SUDs). Using a subset of four randomized [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) (RCTs) included in Project Harmony, an individual patient meta-analysis of 36 RCTs (total N = 4046) of treatments for co-occurring PTSD+SUD, we examined differences in trauma-focused (TF) and non-trauma-focused (non-TF) treatment outcomes for individuals who did and did not endorse baseline cannabis use (N = 410; 70% male; 33.2% endorsed cannabis use). Propensity score-weighted mixed effects modeling evaluated main and interactive effects of treatment assignment (TF versus non-TF) and baseline cannabis use (yes/no) on attendance rates and within-treatment changes in PTSD, alcohol, and non-cannabis drug use severity. Results revealed significant improvements across outcomes among participants in all conditions, with larger PTSD symptom reductions but lower attendance among individuals receiving TF versus non-TF treatment in both cannabis groups. Participants achieved similar reductions in alcohol and drug use across all conditions. TF outperformed non-TF treatments regardless of recent cannabis use, underscoring the importance of reducing barriers to accessing TF treatments for individuals reporting cannabis use. Clinical Perspective This meta-analysis addresses a clinically relevant question about whether cannabis use compromises the effectiveness of trauma-focused therapies in patients with co-occurring PTSD and substance use disorders, drawing data from four RCTs within a larger individual patient meta-analysis. While the study design is methodologically sound, several important caveats warrant consideration: the analysis is limited to a subset of trials with available cannabis use data, causality cannot be established from observational comparisons within RCTs, and the heterogeneity of cannabis use patterns (frequency, potency, timing relative to treatment) may obscure meaningful subgroup differences. Additionally, cannabis use was likely not a primary randomization variable, creating potential confounding by factors such as symptom severity or motivation for treatment that could influence both cannabis use and therapy outcomes. From a clinical standpoint, until we have definitive evidence that cannabis use undermines trauma-focused treatment efficacy in this population, providers should not categorically exclude motivated patients with PTSD and co-occurring cannabis use from evidence  |   |  Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/38266511/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138203/)[DOI ↗](https://doi.org/10.1016/j.janxdis.2024.102827) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System Research: Cannabis for PTSD & SUD](https://cedclinic.com/endocannabinoid-system-ptsd-substance-use-research/) Review research on the endocannabinoid system's role in cannabis treatment for PTSD and substance use disorders. [Read More](https://cedclinic.com/endocannabinoid-system-ptsd-substance-use-research/) [Cannabinoid Clinical Trials: PTSD and Substance Use Data](https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-sud-outcomes/) Explore clinical trial data on cannabinoids for PTSD and co-occurring substance use disorders. [Explore Trials](https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-sud-outcomes/) [Cannabinoids in PTSD and Substance Use: Clinical Evidence](https://cedclinic.com/cannabinoids-ptsd-clinical-evidence/) Examine clinical evidence supporting cannabinoid use in PTSD and substance use disorder treatment. [Learn More](https://cedclinic.com/cannabinoids-ptsd-clinical-evidence/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%20Research%3A%20Cannabis%20PTSD%20Meta-Analysis&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-ptsd-meta-analysis-trauma-focused-treatment%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-ptsd-meta-analysis-trauma-focused-treatment%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%20Research%3A%20Cannabis%20PTSD%20Meta-Analysis%20https%3A%2F%2Fcedclinic.com%2Fcannabis-ptsd-meta-analysis-trauma-focused-treatment%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).